dalteparin
Sign in to saveAlso known as Heparin Fragment KABI 2165, Tedelparin, Fragmin
pharmaceutical drug
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Oligosaccharide
- First approval
- 1994
- Admin. routes
- parenteral
- Indications
- stroke, septic shock, venous thromboembolism, Recurrent thrombophlebitis
via ChEMBL · EBI
Research
1,528 papers- Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.Journal of thrombosis and haemostasis : JTH · 2020
- Dalteparin: a low-molecular-weight heparin.The Annals of pharmacotherapy · 1997
- Dalteparin sodium.Expert opinion on pharmacotherapy · 2001
- Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.Drugs · 2000
- Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.Drugs · 1996
via PubMed
Wikidata facts
- Instance of
- low molecular weight heparin
- Manufacturer
- Pfizer
Show 3 more facts
- medical condition treated
- pulmonary embolism
- physically interacts with
- Serpin family C member 1
- significant drug interaction
- tenoxicam
via Wikidata · CC0